Retrospective Cohort Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Nov 7, 2018; 24(41): 4698-4707
Published online Nov 7, 2018. doi: 10.3748/wjg.v24.i41.4698
Figure 2
Figure 2 Flowchart depicting patient subgroups and outcomes. Overall median follow-up 41 mo (IQR 26-53). OAC: Oesophageal adenocarcinoma; LR: Low-risk tumour; HR: High-risk tumour; IQR: Interquartile range.